This inventor holds 1 USPTO granted patent. Top assignee: Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Pan Hong Jiang: Innovator in Biotherapeutics
Introduction
Pan Hong Jiang is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotherapeutics, particularly through his innovative research and patenting of compounds with lectinic properties. His work has implications for therapeutic applications, especially in the area of immunology.
Latest Patents
Pan Hong Jiang holds a patent for "Compounds having lectinic properties and their biological applications." This invention relates to nucleotide sequences capable of coding for polypeptides with lectinic properties, specifically polypeptides of the sarcolectin type. These polypeptides are utilized in therapeutics to stimulate immunity, often in combination with interferon or butyroids. Additionally, the invention discusses the use of specific inhibitors or antagonist peptides to counteract the production of SCL. Antibodies directed against these peptides can be employed in diagnostics and therapeutics. He has 1 patent to his name.
Career Highlights
Pan Hong Jiang is associated with the Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée, where he continues to advance his research in biotherapeutics. His work is characterized by a strong focus on the intersection of molecular biology and therapeutic applications.
Collaborations
Pan Hong Jiang has collaborated with notable colleagues, including Aboubacar Kaba and Francoise Chany-Fournier, who is a prominent female scientist in the field. Their joint efforts contribute to the advancement of biotherapeutic research and development.
Conclusion
Pan Hong Jiang's innovative work in the field of biotherapeutics highlights the importance of research in developing new therapeutic strategies. His contributions, particularly through his patent, demonstrate the potential of lectinic compounds in enhancing immunity and advancing medical science.